To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Biotechnology leading the way to a greener, more competitive EU future
27-05-2011: Europe must become more resource efficient, which means its leaders must find innovative ways to conserve energy, water and land to ensure that it becomes more sustainable whilst remaining competitive. This is the clear message at DG Environment’s Green Week; which takes place in Brussels this week. EuropaBio is present at the event to mark the quantifiable contributions that biotechnology is making towards a greener and more competitive Europe for today and tomorrow.
Biotechnology is already delivering on resource efficiency in Europe and across the world and its contribution is expected to grow steadily. For example, a WWF report noted that by 2030, 1 billion to 2.5 billion tonnes of CO2 emissions could be avoided through the uptake of industrial biotechnology and bio-based products – more than Germany’s total emissions in 1990. Moreover, in 2009, the equivalent of 7.8 million cars was removed from the road (a decrease of 17.7 billion kg of CO2) thanks to advances in agricultural productivity and the application of agbiotech. Not to mention the simple daily life improvements that biotech applications provide such as the availability of low-temperature washing powders that save energy.
However, if Europe is serious about developing a world-leading resource efficient bio-based economy, a more holistic and strategic approach to policy and funding is needed. In addition, there must be improved production and access to renewable raw materials for industrial use, in sufficient quantity, of good and guaranteed quality and at competitive price which will also provide European farmers with new market opportunities through diversification of their income. In addition, the EU needs to invest in local and regional infrastructures (including biorefineries) and logistical capabilities to allow all biomass, including agricultural, forestry and waste-based raw materials to be efficiently used.
By offering the choice to grow biotech crops, farmers can grow more crops on less land while conserving water and soil not to mention helping to revitalise rural economies, through farming more sustainably and productively whilst improving and securing access to renewable raw materials for industrial use.
According to Nathalie Moll, EuropaBio’s Secretary-General, “Sadly, biotechnology is perhaps the best-kept secret in the search for greater resource efficiency – but it should not remain so. Policymakers must recognise the powerful benefits that biotechnology can have for Europe, its citizens and its farmers. A more integrated, strategic approach is needed if we are serious about developing a globally competitive, resource efficient economy.”
Contact / Request information
Request further information free of charge:
This is where you can add this news to your personal favourites
- 1Pro Bono Bio Launches Flexiseq: A Novel Approach to the Treatment of Osteoarthritis
- 2Rosetta Resolver® Gene Expression Data Analysis System licensed by Aventis Pharmaceuticals, Inc.
- 3Vivacta Initiates Development of Point of Care Test for Vitamin D
- 4Using human brain cells to make mice smarter
- 5Pharma’s New Hero: Supergenerics Save Money and Improve Drugs
- 6Fighting listeria and other food-borne illnesses with nanobiotechnology
- 7A light switch inside the brain
- 8Researchers divide enzyme to conquer genetic puzzle
- 9New study confirms fungal infection of the foot is a risk factor for bacterial tissue infection of the leg
- 10Pharmexa enters into an agreement regarding GV1001 with the Korean company KAEL Co. Ltd
- New angle to combat malignant brain tumors in children
- Ablynx and Spirogen enter in research collaboration for toxin-nanobody drug conjugates
- Bone Therapeutics Invests in Cell Therapy Manufacturing Facility
- Cell therapy a little more concrete thanks to VIB research
- Neupro approved in Japan for Parkinson’s disease and Restless Legs Syndrome